Index by author
November 01, 1993; Volume 267,Issue 2
A
Abercrombie, E D
- You have accessImpact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.D Jackson, E D Abercrombie and M J ZigmondJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 912-918;
Adams, R
- You have access3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.R W Kuncl, D B Drachman, R Adams and M LeharJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 582-589;
Adler, M W
- You have accessSuppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.I Szabo, M Rojavin, J L Bussiere, T K Eisenstein, M W Adler and T J RogersJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 703-706;
Alexandre, I
- You have accessEffects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J RemacleJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;
Arimura, A
- You have accessPassage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.W A Banks, A J Kastin, G Komaki and A ArimuraJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 690-696;
Arnould, T
- You have accessEffects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J RemacleJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;
B
Bakry, N
- You have accessChelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.L L Simpson, J A Coffield and N BakryJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 720-727;
Banks, W A
- You have accessPassage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.W A Banks, A J Kastin, G Komaki and A ArimuraJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 690-696;
Barbanti, G
- You have accessCharacterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A MaggiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
Bell-Quilley, C P
- You have accessRenovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.C P Bell-Quilley, Y S Lin, S D Hilchey, E D Drugge and J C McGiffJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 676-682;
Bend, J R
- You have accessMechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.L C Knickle, C D Webb, A A House and J R BendJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 758-764;
Bergman, J
- You have accessDopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.S Rosenzweig-Lipson and J BergmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 765-775;
Biaggioni, I
- You have accessCaffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets.S Paul, B Kurunwune and I BiaggioniJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 838-843;
Bigelow, G E
- You have accessPrecipitated withdrawal by pentazocine in methadone-maintained volunteers.E C Strain, K L Preston, I A Liebson and G E BigelowJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 624-634;
Biggio, G
- You have accessAnticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G BiggioJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;
Bilsky, E J
- You have accessAntinociceptive actions of BW373U86 in the mouse.K D Wild, J McCormick, E J Bilsky, T Vanderah, R W McNutt, K J Chang and F PorrecaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 858-865;
Black, A
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
Blake, D R
- You have accessMicrovascular substance P binding to normal and inflamed rat and human synovium.D A Walsh, M Salmon, P I Mapp, J Wharton, N Garrett, D R Blake and J M PolakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 951-960;
Blom-Roosemalen, M C
- You have accessPermeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.M A Hurni, A B Noach, M C Blom-Roosemalen, A G de Boer, J F Nagelkerke and D D BreimerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 942-950;
Blumberg, P M
- You have accessCompetitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.A Szallasi, C Goso, P M Blumberg and S ManziniJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 728-733;
Bonhaus, D W
- You have access[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H WongJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;
Bonin, H
- You have accessCellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.T Suzuki, F Nantel, H Bonin, M Valiquette and M BouvierJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 785-790;
Bousley, R
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
Bouvier, M
- You have accessCellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.T Suzuki, F Nantel, H Bonin, M Valiquette and M BouvierJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 785-790;
Breimer, D D
- You have accessPermeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.M A Hurni, A B Noach, M C Blom-Roosemalen, A G de Boer, J F Nagelkerke and D D BreimerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 942-950;
Bryan-Lluka, L J
- You have accessTypes A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.N N Westwood and L J Bryan-LlukaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 815-821;
Burch, R M
- You have accessNPC 15669 reduces mortality associated with sepsis in rats.L Noronha-Blob, V C Lowe, L Otterbein, L Steranka and R M BurchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 664-669;
Burczynski, F J
- You have accessFacilitated dissociation of albumin-fatty acid complexes by rat hepatocytes.F J Burczynski, J B Moran and Z S CaiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 714-719;
Burke, T F
- You have accessEffects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.S S Negus, T F Burke, F Medzihradsky and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 896-903;
Bush, L G
- You have accessDifferential regulation of neuropeptide Y systems in limbic structures of the rat.L P Midgley, L G Bush, J W Gibb and G R HansonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 707-713;
Bussiere, J L
- You have accessSuppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.I Szabo, M Rojavin, J L Bussiere, T K Eisenstein, M W Adler and T J RogersJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 703-706;
C
Cai, Z S
- You have accessFacilitated dissociation of albumin-fatty acid complexes by rat hepatocytes.F J Burczynski, J B Moran and Z S CaiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 714-719;
Chang, K J
- You have accessA novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.K J Chang, G C Rigdon, J L Howard and R W McNuttJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 852-857;
- You have accessAntinociceptive actions of BW373U86 in the mouse.K D Wild, J McCormick, E J Bilsky, T Vanderah, R W McNutt, K J Chang and F PorrecaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 858-865;
- You have accessDiscriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.S D Comer, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 866-874;
- You have accessA novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.L A Dykstra, G M Schoenbaum, J Yarbrough, R McNutt and K J ChangJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 875-882;
- You have accessA nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.P H Lee, R W McNutt and K J ChangJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 883-887;
- You have accessConvulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
Chen, I W
- You have accessRole of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.J H Lin, I W Chen, F A deLuna and M HichensJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 670-675;
Chen, J
- You have accessA study of the dose dependency of a glycine receptor antagonist in focal ischemia.J Chen, S Graham, F Moroni and R SimonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 937-941;
Chiu, A T
- You have accessEXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B TimmermansJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
Cho, H L
- You have accessBronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A SilbaughJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
Chu, T C
- You have accessOcular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.M Ogidigben, T C Chu and D E PotterJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 822-827;
Cockerham, S L
- You have accessBronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A SilbaughJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
Coffield, J A
- You have accessChelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.L L Simpson, J A Coffield and N BakryJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 720-727;
Comer, S D
- You have accessDiscriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.S D Comer, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 866-874;
- You have accessConvulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
Concas, A
- You have accessAnticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G BiggioJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;
Cornicelli, J
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
Culman, J
- You have accessAngiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.F Qadri, J Culman, A Veltmar, K Maas, W Rascher and T UngerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 567-574;
D
Datz, F L
- You have accessEnrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.K A Morton, B J Jones, M H Sohn, F L Datz and R E LynchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 697-702;
Dazzi, L
- You have accessAnticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G BiggioJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;
de Boer, A G
- You have accessPermeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.M A Hurni, A B Noach, M C Blom-Roosemalen, A G de Boer, J F Nagelkerke and D D BreimerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 942-950;
De Costa, B R
- You have accessDiscriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.S D Comer, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 866-874;
- You have accessConvulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
deLuna, F A
- You have accessRole of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.J H Lin, I W Chen, F A deLuna and M HichensJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 670-675;
DeSouza, A
- You have access[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H WongJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;
Diéz Marques, M L
- You have accessCalcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.I Duque, M Rodriguez Puyol, P Ruiz, M Gonzalez-Rubio, M L Diéz Marques and D Rodriguez PuyolJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 612-616;
Dillard, R D
- You have accessBronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A SilbaughJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
Divish, B J
- You have accessAngiotensin II receptor blockade improves renal function in rats with reduced renal mass.D M Pollock, B J Divish, J S Polakowski and T J OpgenorthJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 657-663;
Drachman, D B
- You have access3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.R W Kuncl, D B Drachman, R Adams and M LeharJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 582-589;
Drugge, E D
- You have accessRenovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.C P Bell-Quilley, Y S Lin, S D Hilchey, E D Drugge and J C McGiffJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 676-682;
Duncia, J V
- You have accessEXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B TimmermansJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
Duque, I
- You have accessCalcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.I Duque, M Rodriguez Puyol, P Ruiz, M Gonzalez-Rubio, M L Diéz Marques and D Rodriguez PuyolJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 612-616;
Dykstra, L A
- You have accessA novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.L A Dykstra, G M Schoenbaum, J Yarbrough, R McNutt and K J ChangJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 875-882;
E
Eberle-Wang, K
- You have accessSerotonin-induced muscle contraction in rat stomach fundus is mediated by a G alpha z-like guanine nucleotide binding protein.H Y Wang, K Eberle-Wang, K J Simansky and E FriedmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1002-1011;
Eglen, R M
- You have access[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H WongJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;
Eisenstein, T K
- You have accessSuppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.I Szabo, M Rojavin, J L Bussiere, T K Eisenstein, M W Adler and T J RogersJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 703-706;
Essenburg, A
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
F
Falotico, R
- You have accessRWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.L B Katz, E C Giardino, J J Salata, J B Moore and R FaloticoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 648-656;
Fermini, B
- You have accessMechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue.Z Wang, B Fermini and S NattelJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 575-581;
Fraser, D G
- You have accessRole of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.J F Regal, D G Fraser and C A TothJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 979-988;
Fredholm, B B
- You have accessEffects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.S Jin, B Johansson and B B FredholmJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 801-808;
Frelinger, A L
- You have accessPrevention of experimental carotid artery thrombosis by applaggin.W E Rote, D X Mu, R A Roncinske, A L Frelinger and B R LucchesiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 809-814;
Friedman, E
- You have accessSerotonin-induced muscle contraction in rat stomach fundus is mediated by a G alpha z-like guanine nucleotide binding protein.H Y Wang, K Eberle-Wang, K J Simansky and E FriedmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1002-1011;
Friedman, H
- You have accessDelta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.T W Klein, C Newton, R Widen and H FriedmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 635-640;
Friedman, Z Y
- You have accessTamoxifen and vanadate synergize in causing accumulation of polyphosphoinositides in GH4C1 membranes.Z Y FriedmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 617-623;
Fujitani, Y
- You have accessA selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta.Y Fujitani, H Ueda, T Okada, Y Urade and H KarakiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 683-689;
G
Garrett, N
- You have accessMicrovascular substance P binding to normal and inflamed rat and human synovium.D A Walsh, M Salmon, P I Mapp, J Wharton, N Garrett, D R Blake and J M PolakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 951-960;
Giachetti, A
- You have accessCharacterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A MaggiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
Giardino, E C
- You have accessRWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.L B Katz, E C Giardino, J J Salata, J B Moore and R FaloticoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 648-656;
Gibb, J W
- You have accessDifferential regulation of neuropeptide Y systems in limbic structures of the rat.L P Midgley, L G Bush, J W Gibb and G R HansonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 707-713;
Giuliani, S
- You have accessCharacterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A MaggiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
Goldstein, A
- You have accessCorrelation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.J Stagsted, T Hansen, R A Roth, A Goldstein and L OlssonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 997-1001;
Gonzalez, F J
- You have accessIdentification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase.S Imaoka, P J Wedlund, H Ogawa, S Kimura, F J Gonzalez and H Y KimJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1012-1016;
Gonzalez-Rubio, M
- You have accessCalcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.I Duque, M Rodriguez Puyol, P Ruiz, M Gonzalez-Rubio, M L Diéz Marques and D Rodriguez PuyolJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 612-616;
Goso, C
- You have accessCompetitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.A Szallasi, C Goso, P M Blumberg and S ManziniJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 728-733;
Graham, S
- You have accessA study of the dose dependency of a glycine receptor antagonist in focal ischemia.J Chen, S Graham, F Moroni and R SimonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 937-941;
H
Hansen, T
- You have accessCorrelation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.J Stagsted, T Hansen, R A Roth, A Goldstein and L OlssonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 997-1001;
Hanson, G R
- You have accessDifferential regulation of neuropeptide Y systems in limbic structures of the rat.L P Midgley, L G Bush, J W Gibb and G R HansonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 707-713;
Hatakeyama, K
- You have accessAutoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice.M Hoshiga, K Hatakeyama, M Watanabe, M Shimada and H KagamiyamaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 971-978;
Hichens, M
- You have accessRole of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.J H Lin, I W Chen, F A deLuna and M HichensJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 670-675;
Hilchey, S D
- You have accessRenovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.C P Bell-Quilley, Y S Lin, S D Hilchey, E D Drugge and J C McGiffJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 676-682;
Hirsh, J K
- You have accessAminopyridine block of potassium channels in mouse neuroblastoma cells.J K Hirsh and F N QuandtJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 604-611;
Hoenicke, E M
- You have accessConvulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
Hollenberg, P F
- You have accessEnhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: differential induction kinetics and molecular basis of expression.H Kim, D Putt, S Reddy, P F Hollenberg and R F NovakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 927-936;
Holmes, A
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
Homan, R
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
Hoshiga, M
- You have accessAutoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice.M Hoshiga, K Hatakeyama, M Watanabe, M Shimada and H KagamiyamaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 971-978;
Houbion, A
- You have accessEffects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J RemacleJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;
House, A A
- You have accessMechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.L C Knickle, C D Webb, A A House and J R BendJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 758-764;
Howard, J L
- You have accessA novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.K J Chang, G C Rigdon, J L Howard and R W McNuttJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 852-857;
Hurni, M A
- You have accessPermeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.M A Hurni, A B Noach, M C Blom-Roosemalen, A G de Boer, J F Nagelkerke and D D BreimerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 942-950;
I
Ikegami, Y
- You have accessInsulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.S Noguchi, Y Kashihara, Y Ikegami, K Morimoto, M Miyamoto and K NakaoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 919-926;
Imaoka, S
- You have accessIdentification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase.S Imaoka, P J Wedlund, H Ogawa, S Kimura, F J Gonzalez and H Y KimJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1012-1016;
J
Jackson, D
- You have accessImpact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.D Jackson, E D Abercrombie and M J ZigmondJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 912-918;
Jakeman, L B
- You have access[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H WongJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;
Janssens, D
- You have accessEffects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J RemacleJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;
Jin, S
- You have accessEffects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.S Jin, B Johansson and B B FredholmJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 801-808;
Johansson, B
- You have accessEffects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.S Jin, B Johansson and B B FredholmJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 801-808;
Jones, B J
- You have accessEnrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.K A Morton, B J Jones, M H Sohn, F L Datz and R E LynchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 697-702;
K
Kagamiyama, H
- You have accessAutoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice.M Hoshiga, K Hatakeyama, M Watanabe, M Shimada and H KagamiyamaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 971-978;
Karaki, H
- You have accessA selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta.Y Fujitani, H Ueda, T Okada, Y Urade and H KarakiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 683-689;
Kashihara, Y
- You have accessInsulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.S Noguchi, Y Kashihara, Y Ikegami, K Morimoto, M Miyamoto and K NakaoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 919-926;
Kastin, A J
- You have accessPassage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.W A Banks, A J Kastin, G Komaki and A ArimuraJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 690-696;
Katz, L B
- You have accessRWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.L B Katz, E C Giardino, J J Salata, J B Moore and R FaloticoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 648-656;
Kieft, K
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
Kim, C S
- You have accessTransport of 2,4,5-trichlorophenoxyacetic acid across the blood-cerebrospinal fluid barrier of the rabbit.C S Kim and J B PritchardJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 751-757;
Kim, H
- You have accessEnhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: differential induction kinetics and molecular basis of expression.H Kim, D Putt, S Reddy, P F Hollenberg and R F NovakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 927-936;
Kim, H Y
- You have accessIdentification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase.S Imaoka, P J Wedlund, H Ogawa, S Kimura, F J Gonzalez and H Y KimJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1012-1016;
Kimura, S
- You have accessIdentification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase.S Imaoka, P J Wedlund, H Ogawa, S Kimura, F J Gonzalez and H Y KimJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1012-1016;
Klein, T W
- You have accessDelta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.T W Klein, C Newton, R Widen and H FriedmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 635-640;
Kline, J A
- You have accessInsulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.J A Kline, C A Tomaszewski, J D Schroeder and R M RaymondJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 744-750;
Knickle, L C
- You have accessMechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.L C Knickle, C D Webb, A A House and J R BendJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 758-764;
Komaki, G
- You have accessPassage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier.W A Banks, A J Kastin, G Komaki and A ArimuraJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 690-696;
Krause, B R
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
Kuncl, R W
- You have access3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.R W Kuncl, D B Drachman, R Adams and M LeharJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 582-589;
Kurunwune, B
- You have accessCaffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets.S Paul, B Kurunwune and I BiaggioniJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 838-843;
L
Lee, P H
- You have accessA nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.P H Lee, R W McNutt and K J ChangJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 883-887;
Lehar, M
- You have access3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.R W Kuncl, D B Drachman, R Adams and M LeharJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 582-589;
Liebson, I A
- You have accessPrecipitated withdrawal by pentazocine in methadone-maintained volunteers.E C Strain, K L Preston, I A Liebson and G E BigelowJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 624-634;
Lin, J H
- You have accessRole of calcium in plasma protein binding and renal handling of alendronate in hypo- and hypercalcemic rats.J H Lin, I W Chen, F A deLuna and M HichensJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 670-675;
Lin, Y S
- You have accessRenovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.C P Bell-Quilley, Y S Lin, S D Hilchey, E D Drugge and J C McGiffJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 676-682;
Loury, D N
- You have access[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H WongJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;
Lowe, V C
- You have accessNPC 15669 reduces mortality associated with sepsis in rats.L Noronha-Blob, V C Lowe, L Otterbein, L Steranka and R M BurchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 664-669;
Lucchesi, B R
- You have accessPrevention of experimental carotid artery thrombosis by applaggin.W E Rote, D X Mu, R A Roncinske, A L Frelinger and B R LucchesiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 809-814;
Lynch, R E
- You have accessEnrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.K A Morton, B J Jones, M H Sohn, F L Datz and R E LynchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 697-702;
M
Maas, K
- You have accessAngiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.F Qadri, J Culman, A Veltmar, K Maas, W Rascher and T UngerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 567-574;
Maciocco, E
- You have accessAnticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G BiggioJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;
Maggi, C A
- You have accessCharacterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A MaggiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
Manzini, S
- You have accessCompetitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.A Szallasi, C Goso, P M Blumberg and S ManziniJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 728-733;
Mapp, P I
- You have accessMicrovascular substance P binding to normal and inflamed rat and human synovium.D A Walsh, M Salmon, P I Mapp, J Wharton, N Garrett, D R Blake and J M PolakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 951-960;
Mascia, M P
- You have accessAnticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G BiggioJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;
McCormick, J
- You have accessAntinociceptive actions of BW373U86 in the mouse.K D Wild, J McCormick, E J Bilsky, T Vanderah, R W McNutt, K J Chang and F PorrecaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 858-865;
McGiff, J C
- You have accessRenovascular actions of angiotensin II in the isolated kidney of the rat: relationship to lipoxygenases.C P Bell-Quilley, Y S Lin, S D Hilchey, E D Drugge and J C McGiffJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 676-682;
McIvor, R S
- You have accessSelective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.D B Vinh and R S McIvorJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 989-996;
McNutt, R
- You have accessA novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.L A Dykstra, G M Schoenbaum, J Yarbrough, R McNutt and K J ChangJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 875-882;
McNutt, R W
- You have accessA novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.K J Chang, G C Rigdon, J L Howard and R W McNuttJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 852-857;
- You have accessAntinociceptive actions of BW373U86 in the mouse.K D Wild, J McCormick, E J Bilsky, T Vanderah, R W McNutt, K J Chang and F PorrecaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 858-865;
- You have accessDiscriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.S D Comer, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 866-874;
- You have accessA nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.P H Lee, R W McNutt and K J ChangJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 883-887;
- You have accessConvulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
Medzihradsky, F
- You have accessEffects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.S S Negus, T F Burke, F Medzihradsky and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 896-903;
Michiels, C
- You have accessEffects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J RemacleJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;
Midgley, L P
- You have accessDifferential regulation of neuropeptide Y systems in limbic structures of the rat.L P Midgley, L G Bush, J W Gibb and G R HansonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 707-713;
Miyamoto, M
- You have accessInsulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.S Noguchi, Y Kashihara, Y Ikegami, K Morimoto, M Miyamoto and K NakaoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 919-926;
Moore, J B
- You have accessRWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.L B Katz, E C Giardino, J J Salata, J B Moore and R FaloticoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 648-656;
Moran, J B
- You have accessFacilitated dissociation of albumin-fatty acid complexes by rat hepatocytes.F J Burczynski, J B Moran and Z S CaiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 714-719;
Morimoto, K
- You have accessInsulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.S Noguchi, Y Kashihara, Y Ikegami, K Morimoto, M Miyamoto and K NakaoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 919-926;
Moroni, F
- You have accessA study of the dose dependency of a glycine receptor antagonist in focal ischemia.J Chen, S Graham, F Moroni and R SimonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 937-941;
Morton, K A
- You have accessEnrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.K A Morton, B J Jones, M H Sohn, F L Datz and R E LynchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 697-702;
Mosberg, H I
- You have accessDiscriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.S D Comer, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 866-874;
- You have accessConvulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
Mu, D X
- You have accessPrevention of experimental carotid artery thrombosis by applaggin.W E Rote, D X Mu, R A Roncinske, A L Frelinger and B R LucchesiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 809-814;
N
Nagelkerke, J F
- You have accessPermeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.M A Hurni, A B Noach, M C Blom-Roosemalen, A G de Boer, J F Nagelkerke and D D BreimerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 942-950;
Nakao, K
- You have accessInsulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.S Noguchi, Y Kashihara, Y Ikegami, K Morimoto, M Miyamoto and K NakaoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 919-926;
Nantel, F
- You have accessCellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.T Suzuki, F Nantel, H Bonin, M Valiquette and M BouvierJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 785-790;
Nattel, S
- You have accessMechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue.Z Wang, B Fermini and S NattelJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 575-581;
Negus, S S
- You have accessEffects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.S S Negus, T F Burke, F Medzihradsky and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 896-903;
Newton, C
- You have accessDelta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.T W Klein, C Newton, R Widen and H FriedmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 635-640;
Noach, A B
- You have accessPermeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy.M A Hurni, A B Noach, M C Blom-Roosemalen, A G de Boer, J F Nagelkerke and D D BreimerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 942-950;
Noguchi, S
- You have accessInsulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.S Noguchi, Y Kashihara, Y Ikegami, K Morimoto, M Miyamoto and K NakaoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 919-926;
Noronha-Blob, L
- You have accessNPC 15669 reduces mortality associated with sepsis in rats.L Noronha-Blob, V C Lowe, L Otterbein, L Steranka and R M BurchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 664-669;
Novak, R F
- You have accessEnhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: differential induction kinetics and molecular basis of expression.H Kim, D Putt, S Reddy, P F Hollenberg and R F NovakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 927-936;
O
Obenchain, R L
- You have accessBronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A SilbaughJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
Ogawa, H
- You have accessIdentification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase.S Imaoka, P J Wedlund, H Ogawa, S Kimura, F J Gonzalez and H Y KimJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1012-1016;
Ogidigben, M
- You have accessOcular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.M Ogidigben, T C Chu and D E PotterJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 822-827;
Okada, T
- You have accessA selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta.Y Fujitani, H Ueda, T Okada, Y Urade and H KarakiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 683-689;
Olson, R E
- You have accessEXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B TimmermansJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
Olsson, L
- You have accessCorrelation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.J Stagsted, T Hansen, R A Roth, A Goldstein and L OlssonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 997-1001;
Ongini, E
- You have accessAnticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G BiggioJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;
Opgenorth, T J
- You have accessAngiotensin II receptor blockade improves renal function in rats with reduced renal mass.D M Pollock, B J Divish, J S Polakowski and T J OpgenorthJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 657-663;
Otterbein, L
- You have accessNPC 15669 reduces mortality associated with sepsis in rats.L Noronha-Blob, V C Lowe, L Otterbein, L Steranka and R M BurchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 664-669;
P
Patacchini, R
- You have accessCharacterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A MaggiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
Paul, S
- You have accessCaffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets.S Paul, B Kurunwune and I BiaggioniJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 838-843;
Pechous, P A
- You have accessBronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A SilbaughJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
Polak, J M
- You have accessMicrovascular substance P binding to normal and inflamed rat and human synovium.D A Walsh, M Salmon, P I Mapp, J Wharton, N Garrett, D R Blake and J M PolakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 951-960;
Polakowski, J S
- You have accessAngiotensin II receptor blockade improves renal function in rats with reduced renal mass.D M Pollock, B J Divish, J S Polakowski and T J OpgenorthJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 657-663;
Pollock, D M
- You have accessAngiotensin II receptor blockade improves renal function in rats with reduced renal mass.D M Pollock, B J Divish, J S Polakowski and T J OpgenorthJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 657-663;
Porreca, F
- You have accessAntinociceptive actions of BW373U86 in the mouse.K D Wild, J McCormick, E J Bilsky, T Vanderah, R W McNutt, K J Chang and F PorrecaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 858-865;
Potter, D E
- You have accessOcular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.M Ogidigben, T C Chu and D E PotterJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 822-827;
Preston, K L
- You have accessPrecipitated withdrawal by pentazocine in methadone-maintained volunteers.E C Strain, K L Preston, I A Liebson and G E BigelowJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 624-634;
Pritchard, J B
- You have accessTransport of 2,4,5-trichlorophenoxyacetic acid across the blood-cerebrospinal fluid barrier of the rabbit.C S Kim and J B PritchardJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 751-757;
Putt, D
- You have accessEnhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: differential induction kinetics and molecular basis of expression.H Kim, D Putt, S Reddy, P F Hollenberg and R F NovakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 927-936;
Q
Qadri, F
- You have accessAngiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.F Qadri, J Culman, A Veltmar, K Maas, W Rascher and T UngerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 567-574;
Quandt, F N
- You have accessAminopyridine block of potassium channels in mouse neuroblastoma cells.J K Hirsh and F N QuandtJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 604-611;
Quartara, L
- You have accessCharacterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A MaggiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
R
Rascher, W
- You have accessAngiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.F Qadri, J Culman, A Veltmar, K Maas, W Rascher and T UngerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 567-574;
Raymond, R M
- You have accessInsulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.J A Kline, C A Tomaszewski, J D Schroeder and R M RaymondJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 744-750;
Reddy, S
- You have accessEnhanced expression of rat hepatic CYP2B1/2B2 and 2E1 by pyridine: differential induction kinetics and molecular basis of expression.H Kim, D Putt, S Reddy, P F Hollenberg and R F NovakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 927-936;
Regal, J F
- You have accessRole of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.J F Regal, D G Fraser and C A TothJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 979-988;
Remacle, J
- You have accessEffects of naftidrofuryl on hypoxia-induced activation and mortality of human endothelial cells.C Michiels, T Arnould, D Janssens, I Alexandre, A Houbion and J RemacleJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 904-911;
Riekkinen, M
- You have accessEffects of nicotine on neocortical electrical activity in rats.P Riekkinen, M Riekkinen and J SirviöJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 776-784;
Riekkinen, P
- You have accessEffects of nicotine on neocortical electrical activity in rats.P Riekkinen, M Riekkinen and J SirviöJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 776-784;
Rigdon, G C
- You have accessA novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.K J Chang, G C Rigdon, J L Howard and R W McNuttJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 852-857;
Rodriguez Puyol, D
- You have accessCalcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.I Duque, M Rodriguez Puyol, P Ruiz, M Gonzalez-Rubio, M L Diéz Marques and D Rodriguez PuyolJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 612-616;
Rodriguez Puyol, M
- You have accessCalcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.I Duque, M Rodriguez Puyol, P Ruiz, M Gonzalez-Rubio, M L Diéz Marques and D Rodriguez PuyolJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 612-616;
Rogers, T J
- You have accessSuppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.I Szabo, M Rojavin, J L Bussiere, T K Eisenstein, M W Adler and T J RogersJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 703-706;
Rojavin, M
- You have accessSuppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.I Szabo, M Rojavin, J L Bussiere, T K Eisenstein, M W Adler and T J RogersJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 703-706;
Rominger, D H
- You have accessEXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B TimmermansJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
Roncinske, R A
- You have accessPrevention of experimental carotid artery thrombosis by applaggin.W E Rote, D X Mu, R A Roncinske, A L Frelinger and B R LucchesiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 809-814;
Rosenzweig-Lipson, S
- You have accessDopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.S Rosenzweig-Lipson and J BergmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 765-775;
Rote, W E
- You have accessPrevention of experimental carotid artery thrombosis by applaggin.W E Rote, D X Mu, R A Roncinske, A L Frelinger and B R LucchesiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 809-814;
Roth, R A
- You have accessCorrelation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.J Stagsted, T Hansen, R A Roth, A Goldstein and L OlssonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 997-1001;
Rovero, P
- You have accessCharacterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A MaggiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
Ruiz, P
- You have accessCalcium channel blockers inhibit hydrogen peroxide-induced proliferation of cultured rat mesangial cells.I Duque, M Rodriguez Puyol, P Ruiz, M Gonzalez-Rubio, M L Diéz Marques and D Rodriguez PuyolJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 612-616;
S
Sable, A I
- You have accessConvulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
Salata, J J
- You have accessRWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.L B Katz, E C Giardino, J J Salata, J B Moore and R FaloticoJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 648-656;
Salmon, M
- You have accessMicrovascular substance P binding to normal and inflamed rat and human synovium.D A Walsh, M Salmon, P I Mapp, J Wharton, N Garrett, D R Blake and J M PolakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 951-960;
Santoro, G
- You have accessAnticonvulsant doses of 2-chloro-N6-cyclopentyladenosine, an adenosine A1 receptor agonist, reduce GABAergic transmission in different areas of the mouse brain.A Concas, G Santoro, M P Mascia, E Maciocco, L Dazzi, E Ongini and G BiggioJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 844-851;
Schoenbaum, G M
- You have accessA novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.L A Dykstra, G M Schoenbaum, J Yarbrough, R McNutt and K J ChangJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 875-882;
Schroeder, J D
- You have accessInsulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.J A Kline, C A Tomaszewski, J D Schroeder and R M RaymondJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 744-750;
Sekerke, C
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
Shaw-Hes, M K
- You have accessDivergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.B R Krause, A Black, R Bousley, A Essenburg, J Cornicelli, A Holmes, R Homan, K Kieft, C Sekerke and M K Shaw-HesJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 734-743;
Shimada, M
- You have accessAutoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice.M Hoshiga, K Hatakeyama, M Watanabe, M Shimada and H KagamiyamaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 971-978;
Silbaugh, S A
- You have accessBronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A SilbaughJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
Simansky, K J
- You have accessSerotonin-induced muscle contraction in rat stomach fundus is mediated by a G alpha z-like guanine nucleotide binding protein.H Y Wang, K Eberle-Wang, K J Simansky and E FriedmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1002-1011;
Simon, R
- You have accessA study of the dose dependency of a glycine receptor antagonist in focal ischemia.J Chen, S Graham, F Moroni and R SimonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 937-941;
Simpson, L L
- You have accessChelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.L L Simpson, J A Coffield and N BakryJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 720-727;
Sirviö, J
- You have accessEffects of nicotine on neocortical electrical activity in rats.P Riekkinen, M Riekkinen and J SirviöJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 776-784;
Snyder, D W
- You have accessBronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A SilbaughJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
Sohn, M H
- You have accessEnrichment for metallothionein does not confer resistance to cisplatin in transfected NIH/3T3 cells.K A Morton, B J Jones, M H Sohn, F L Datz and R E LynchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 697-702;
Spaethe, S M
- You have accessBronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A SilbaughJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
Stagsted, J
- You have accessCorrelation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.J Stagsted, T Hansen, R A Roth, A Goldstein and L OlssonJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 997-1001;
Stengel, P W
- You have accessBronchopulmonary actions of 1-(1,2,3,4-tetrahydro-1-naphthylenyl)-1H-imidazole, nitric acid salt (LY150310), a substituted imidazole, in the guinea pig.P W Stengel, R D Dillard, H L Cho, D W Snyder, S M Spaethe, P A Pechous, R L Obenchain, S L Cockerham and S A SilbaughJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 596-603;
Steranka, L
- You have accessNPC 15669 reduces mortality associated with sepsis in rats.L Noronha-Blob, V C Lowe, L Otterbein, L Steranka and R M BurchJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 664-669;
Strain, E C
- You have accessPrecipitated withdrawal by pentazocine in methadone-maintained volunteers.E C Strain, K L Preston, I A Liebson and G E BigelowJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 624-634;
Suzuki, T
- You have accessCellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.T Suzuki, F Nantel, H Bonin, M Valiquette and M BouvierJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 785-790;
Szabo, I
- You have accessSuppression of peritoneal macrophage phagocytosis of Candida albicans by opioids.I Szabo, M Rojavin, J L Bussiere, T K Eisenstein, M W Adler and T J RogersJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 703-706;
Szallasi, A
- You have accessCompetitive inhibition by capsazepine of [3H]resiniferatoxin binding to central (spinal cord and dorsal root ganglia) and peripheral (urinary bladder and airways) vanilloid (capsaicin) receptors in the rat.A Szallasi, C Goso, P M Blumberg and S ManziniJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 728-733;
T
Tam, S W
- You have accessEXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B TimmermansJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
Thalody, G P
- You have accessDifferential attenuation of the responses to adenosine and methoxamine in isolated rabbit aorta.H L Wiener and G P ThalodyJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 828-837;
Timmermans, P B
- You have accessEXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B TimmermansJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
To, Z
- You have access[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H WongJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;
Tomaszewski, C A
- You have accessInsulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine.J A Kline, C A Tomaszewski, J D Schroeder and R M RaymondJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 744-750;
Toth, C A
- You have accessRole of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.J F Regal, D G Fraser and C A TothJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 979-988;
Turini, D
- You have accessCharacterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.S Giuliani, R Patacchini, G Barbanti, D Turini, P Rovero, L Quartara, A Giachetti and C A MaggiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 590-595;
U
Ueda, H
- You have accessA selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta.Y Fujitani, H Ueda, T Okada, Y Urade and H KarakiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 683-689;
Unger, T
- You have accessAngiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.F Qadri, J Culman, A Veltmar, K Maas, W Rascher and T UngerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 567-574;
Urade, Y
- You have accessA selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta.Y Fujitani, H Ueda, T Okada, Y Urade and H KarakiJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 683-689;
V
Valiquette, M
- You have accessCellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.T Suzuki, F Nantel, H Bonin, M Valiquette and M BouvierJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 785-790;
Vanderah, T
- You have accessAntinociceptive actions of BW373U86 in the mouse.K D Wild, J McCormick, E J Bilsky, T Vanderah, R W McNutt, K J Chang and F PorrecaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 858-865;
Veltmar, A
- You have accessAngiotensin II-induced vasopressin release is mediated through alpha-1 adrenoceptors and angiotensin II AT1 receptors in the supraoptic nucleus.F Qadri, J Culman, A Veltmar, K Maas, W Rascher and T UngerJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 567-574;
Vinh, D B
- You have accessSelective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.D B Vinh and R S McIvorJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 989-996;
W
Walsh, D A
- You have accessMicrovascular substance P binding to normal and inflamed rat and human synovium.D A Walsh, M Salmon, P I Mapp, J Wharton, N Garrett, D R Blake and J M PolakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 951-960;
Wang, H Y
- You have accessSerotonin-induced muscle contraction in rat stomach fundus is mediated by a G alpha z-like guanine nucleotide binding protein.H Y Wang, K Eberle-Wang, K J Simansky and E FriedmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1002-1011;
Wang, Z
- You have accessMechanism of flecainide's rate-dependent actions on action potential duration in canine atrial tissue.Z Wang, B Fermini and S NattelJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 575-581;
Watanabe, M
- You have accessAutoradiographic distribution of [14C]tetrahydrobiopterin and its developmental change in mice.M Hoshiga, K Hatakeyama, M Watanabe, M Shimada and H KagamiyamaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 971-978;
Webb, C D
- You have accessMechanism-based inactivation of cytochrome P450 1A1 by N-aralkyl-1-aminobenzotriazoles in guinea pig kidney in vivo and in vitro: minimal effects on metabolism of arachidonic acid by renal P450-dependent monooxygenases.L C Knickle, C D Webb, A A House and J R BendJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 758-764;
Wedlund, P J
- You have accessIdentification of CYP2C23 expressed in rat kidney as an arachidonic acid epoxygenase.S Imaoka, P J Wedlund, H Ogawa, S Kimura, F J Gonzalez and H Y KimJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 1012-1016;
Westwood, N N
- You have accessTypes A and B monoamine oxidase contribute to the metabolism of norepinephrine in perfused lungs of rats.N N Westwood and L J Bryan-LlukaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 815-821;
Wharton, J
- You have accessMicrovascular substance P binding to normal and inflamed rat and human synovium.D A Walsh, M Salmon, P I Mapp, J Wharton, N Garrett, D R Blake and J M PolakJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 951-960;
Widen, R
- You have accessDelta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.T W Klein, C Newton, R Widen and H FriedmanJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 635-640;
Wiener, H L
- You have accessDifferential attenuation of the responses to adenosine and methoxamine in isolated rabbit aorta.H L Wiener and G P ThalodyJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 828-837;
Wild, K D
- You have accessAntinociceptive actions of BW373U86 in the mouse.K D Wild, J McCormick, E J Bilsky, T Vanderah, R W McNutt, K J Chang and F PorrecaJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 858-865;
Wong, E H
- You have access[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus.D W Bonhaus, D N Loury, L B Jakeman, Z To, A DeSouza, R M Eglen and E H WongJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 961-970;
Wong, P C
- You have accessEXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.P C Wong, J V Duncia, A T Chiu, R E Olson, D H Rominger, S W Tam and P B TimmermansJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 641-647;
Woods, J H
- You have accessDiscriminative stimulus effects of BW373U86: a nonpeptide ligand with selectivity for delta opioid receptors.S D Comer, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 866-874;
- You have accessConvulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.S D Comer, E M Hoenicke, A I Sable, R W McNutt, K J Chang, B R De Costa, H I Mosberg and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 888-895;
- You have accessEffects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine.S S Negus, T F Burke, F Medzihradsky and J H WoodsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 896-903;
Y
Yarbrough, J
- You have accessA novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.L A Dykstra, G M Schoenbaum, J Yarbrough, R McNutt and K J ChangJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 875-882;
Z
Zalups, R K
- You have accessInfluence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.R K ZalupsJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 791-800;
Zigmond, M J
- You have accessImpact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.D Jackson, E D Abercrombie and M J ZigmondJournal of Pharmacology and Experimental Therapeutics November 1993, 267 (2) 912-918;
In this issue
Advertisement